Home  >  Products  >  MAD2L1BP (MAD2L1 binding protein ) Blocking Peptide (the N terminal of MAD2L1BP)(100ug)
MAD2L1BP (MAD2L1 binding protein ) Blocking Peptide (the N terminal of MAD2L1BP)(100ug)

MAD2L1BP (MAD2L1 binding protein ) Blocking Peptide (the N terminal of MAD2L1BP)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MAD2L1BP Antibody (ARP61356_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61356
Size: 100ug
Weight: 30kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The protein encoded by this gene was identified as a binding protein of the MAD2 mitotic arrest deficient-like 1 (MAD2/MAD2L1). MAD2 is a key component of the spindle checkpoint that delays the onset of anaphase until all the kinetochores are attached to the spindle. This protein may interact with the spindle checkpoint and coordinate cell cycle events in late mitosis.
Alternative names: CMT2; KIAA0110; MGC11282; RP1-261G23.6
See Full Product Listings >